Janet Pope Janetbirdope
3 years 6 months ago
Sounds fishy! Krill oil in #osteoarthritis is not a good catch! Fully neg RCT POS0276 @eular_org @RheumNow #EULAR2021 https://t.co/OGZbltDyxg
Eric Dein ejdein1
3 years 6 months ago
How many of your postmenopausal RA ♀️ patients are on osteoporotic treatment?
#EULAR2021 POS0164
⭐️28% had prior fragility FX
⭐️50.5% at very high or high risk of fx according to FRAX 10 yr major fx risk
Over 1/2 of patients at risk & indicated for treatment!
@RheumNow
Janet Pope Janetbirdope
3 years 6 months ago
Who responds better to bDMARDs in RA, PsA & SpA? Men, women or equal? POS0208 #EULAR2021 @RheumNow @eular_org
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 6 months ago
2021 GRAPPA STRONG recs (cont'd):
*⃣Crohn's Dz & UC: TNFi (not ETN), IL12/23i
🚫strong rec against IL17i
2021 GRAPPA CONDITIONAL recs for:
*⃣ Uveitis: TNFi (not ETN), CyA
*⃣ Crohn's Dz & UC: IL23i, JAKi, MTX
OP0229 #EULAR2021 @RheumNow https://t.co/AWyKqSapWG
Jeffrey Sparks MD MMSc jeffsparks
3 years 6 months ago
Lots of discussion about RA-ILD, but what about bronchiectasis (BR) in RA? We found a pooled prevalence of RA-BR of 18.7% (some may have been subclinical). POS0522 Prevalence of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis #EULAR2021 @Janetbirdope
Janet Pope Janetbirdope
3 years 6 months ago
Sex differences in response to bDMARDs in RA, PsA & SpA? YES. Data from BIOREG- 477 RA, 150 PsA, 312 SpA treated with rap TNFi. Men respond better to TNFi in all groups POS0208 #EULAR2021 @RheumNow @eular_org https://t.co/7FoI3p0qwe
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 6 months ago
2021 GRAPPA STRONG recs: *⃣Axial PsA/arthritis, biologic-naive or IR: TNFi, IL17i, JAKi *⃣Peripheral arthritis biologic-IR: above + IL23i *⃣Peripheral arthritis DMARD-IR: above + IL12/23i *⃣Peripheral arthritis DMARD-naive: above + PDE4i + csDMARD OP0229 #EULAR2021 @RheumNow https://t.co/Z2Nv073yoU
Janet Pope Janetbirdope
3 years 6 months ago
wonder if vit D is a surrogate for poor health, low SES, diet? In #SARSCoV2 infection low vit D has worse outcomes but clusters racially (⬇️ by skin tone) & seems related to SES. But perhaps adding vit D can help immune system & be anti-inflammatory #EULAR2021 @RheumNow POS0100 https://t.co/TEf52bLs0i
Robert B Chao, MD doctorRBC
3 years 6 months ago
Deucravacitinib (TYK2i) - phase II trial for PsA ⭐️ACR20, 50, 70 response ⭐️HAQ-DI response ⭐️LEI/SPARCC response ⭐️MDA response Abs#OP0227 #EULAR2021 @RheumNow
Robert B Chao, MD doctorRBC
3 years 6 months ago
Risankizumab (IL-23i) phase III trial for PsA inadequate response to biologic
⭐️ACR20, 50,70 response
⭐️significant resolution of enthesitis/dactylitis
Abs#OP0228
#EULAR2021 @RheumNow
Robert B Chao, MD doctorRBC
3 years 6 months ago
Latest GRAPPA guidelines for treatment of PsA
Abs#OP0229
#EULAR2021 @RheumNow https://t.co/YlHHQsFGC8
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 6 months ago
What can define +MRI for active spine lesions in axSpA?
*⃣ BME in >/=4 vertebral corners (VCs)
*⃣BME in >/= 3 VCs if w/ at least 1 non-corner inflamm lesion
*⃣BME in >/=1 VC if w/ at least 2 VC fat lesions
Such cut-offs achieve >/= 95% specificity
OP0252. #EULAR2021 @Rheumnow https://t.co/5CTan2BgLK
Robert B Chao, MD doctorRBC
3 years 6 months ago
Lower ILD incidence in PsA than RA in a large Nordic registry
⭐️ No significant ⬆️ in ILD in those using MTX
Abs#OP0222
#EULAR2021 @RheumNow https://t.co/lgGhu1Hmd6